tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Fresenius Medical price target raised to EUR 52.50 from EUR 46.50 at Citi
PremiumThe FlyFresenius Medical price target raised to EUR 52.50 from EUR 46.50 at Citi
1M ago
Fresenius Medical price target raised to EUR 43 from EUR 41 at Morgan Stanley
Premium
The Fly
Fresenius Medical price target raised to EUR 43 from EUR 41 at Morgan Stanley
2M ago
Fresenius Medical price target raised to $30 from $25 at Truist
Premium
The Fly
Fresenius Medical price target raised to $30 from $25 at Truist
2M ago
Fresenius Medical price target raised to EUR 41.50 from EUR 37.30 at JPMorgan
PremiumThe FlyFresenius Medical price target raised to EUR 41.50 from EUR 37.30 at JPMorgan
5M ago
Cautious Optimism: Hold Rating for Fresenius Medical Care Amid Positive Q3 Performance and 2025 Growth Projections
Premium
Ratings
Cautious Optimism: Hold Rating for Fresenius Medical Care Amid Positive Q3 Performance and 2025 Growth Projections
5M ago
Fresenius Medical price target raised to EUR 39 from EUR 37 at Morgan Stanley
Premium
The Fly
Fresenius Medical price target raised to EUR 39 from EUR 37 at Morgan Stanley
5M ago
Fresenius Medical price target raised to $25 from $23 at Truist
PremiumThe FlyFresenius Medical price target raised to $25 from $23 at Truist
6M ago
Cara Therapeutics, Tvardi Therapeutics enter definitive merger agreement
Premium
The Fly
Cara Therapeutics, Tvardi Therapeutics enter definitive merger agreement
7M ago
Fresenius Medical upgraded to Neutral from Underperform at BofA
Premium
The Fly
Fresenius Medical upgraded to Neutral from Underperform at BofA
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100